Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)

Takahiro Nakazawa; Terumi Kamisawa; Kazuichi Okazaki; Shigeyuki Kawa; Susumu Tazuma; Takayoshi Nishino; Dai Inoue; Itaru Naitoh; Takayuki Watanabe; Kenji Notohara; Kensuke Kubota; Hirotaka Ohara; Atsushi Tanaka; Hajime Takikawa; Atsushi Masamune; Michiaki Unno

doi:10.1002/jhbp.913

Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)

Takahiro Nakazawa, Terumi Kamisawa, Kazuichi Okazaki, Shigeyuki Kawa, Susumu Tazuma, Takayoshi Nishino, Dai Inoue, Itaru Naitoh, Takayuki Watanabe, Kenji Notohara, Kensuke Kubota, Hirotaka Ohara, Atsushi Tanaka, Hajime Takikawa, Atsushi Masamune, Michiaki Unno

MED - Medical Sciences

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Several years have passed since the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then. The Research Committees for IgG4-related Diseases and for Intractable Diseases of the Liver and Biliary Tract, in association with the Ministry of Health, Labor, and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4-SC and have drawn up new clinical diagnostic criteria for IgG4-SC 2020. The diagnosis of IgG4-SC is based on a combination of the following six criteria: (a) narrowing of the intra- or extrahepatic bile duct; (b) thickening of the bile duct wall; (c) serological findings; (d) pathological findings; (e) other organ involvement; and (f) effectiveness of steroid therapy. These new diagnostic criteria for IgG4-SC are useful in practice for general physicians and other non-specialists.

Original language	English
Pages (from-to)	235-242
Number of pages	8
Journal	Journal of Hepato-Biliary-Pancreatic Sciences
Volume	28
Issue number	3
DOIs	https://doi.org/10.1002/jhbp.913
Publication status	Published - 2021 Mar

ASJC Scopus subject areas

Surgery
Hepatology

Access to Document

10.1002/jhbp.913

Cite this

Nakazawa, T., Kamisawa, T., Okazaki, K., Kawa, S., Tazuma, S., Nishino, T., Inoue, D., Naitoh, I., Watanabe, T., Notohara, K., Kubota, K., Ohara, H., Tanaka, A., Takikawa, H., Masamune, A., & Unno, M. (2021). Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012). Journal of Hepato-Biliary-Pancreatic Sciences, 28(3), 235-242. https://doi.org/10.1002/jhbp.913

Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012). / Nakazawa, Takahiro; Kamisawa, Terumi; Okazaki, Kazuichi et al.
In: Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 28, No. 3, 03.2021, p. 235-242.

Research output: Contribution to journal › Article › peer-review

Nakazawa, T, Kamisawa, T, Okazaki, K, Kawa, S, Tazuma, S, Nishino, T, Inoue, D, Naitoh, I, Watanabe, T, Notohara, K, Kubota, K, Ohara, H, Tanaka, A, Takikawa, H, Masamune, A & Unno, M 2021, 'Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)', Journal of Hepato-Biliary-Pancreatic Sciences, vol. 28, no. 3, pp. 235-242. https://doi.org/10.1002/jhbp.913

@article{6a6cf603b1504f0491c32dabd04c3191,

title = "Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)",

abstract = "Several years have passed since the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then. The Research Committees for IgG4-related Diseases and for Intractable Diseases of the Liver and Biliary Tract, in association with the Ministry of Health, Labor, and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4-SC and have drawn up new clinical diagnostic criteria for IgG4-SC 2020. The diagnosis of IgG4-SC is based on a combination of the following six criteria: (a) narrowing of the intra- or extrahepatic bile duct; (b) thickening of the bile duct wall; (c) serological findings; (d) pathological findings; (e) other organ involvement; and (f) effectiveness of steroid therapy. These new diagnostic criteria for IgG4-SC are useful in practice for general physicians and other non-specialists.",

author = "Takahiro Nakazawa and Terumi Kamisawa and Kazuichi Okazaki and Shigeyuki Kawa and Susumu Tazuma and Takayoshi Nishino and Dai Inoue and Itaru Naitoh and Takayuki Watanabe and Kenji Notohara and Kensuke Kubota and Hirotaka Ohara and Atsushi Tanaka and Hajime Takikawa and Atsushi Masamune and Michiaki Unno",

note = "Funding Information: These guidelines were created collaboratively by the Japan Biliary Association, the Research Programs of Intractable Disease for IgG4-related Disease and Intractable Hepato-Biliary Diseases provided by the Ministry of Health, Labor, and Welfare of Japan. This study was supported by a grand-in-aid for the Research Program of Intractable Disease for IgG4-related Disease provided by the Ministry of Health, Labor, and Welfare of Japan. Publisher Copyright: {\textcopyright} 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery",

year = "2021",

month = mar,

doi = "10.1002/jhbp.913",

language = "English",

volume = "28",

pages = "235--242",

journal = "Journal of Hepato-Biliary-Pancreatic Sciences",

issn = "1868-6974",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020

T2 - (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)

AU - Nakazawa, Takahiro

AU - Kamisawa, Terumi

AU - Okazaki, Kazuichi

AU - Kawa, Shigeyuki

AU - Tazuma, Susumu

AU - Nishino, Takayoshi

AU - Inoue, Dai

AU - Naitoh, Itaru

AU - Watanabe, Takayuki

AU - Notohara, Kenji

AU - Kubota, Kensuke

AU - Ohara, Hirotaka

AU - Tanaka, Atsushi

AU - Takikawa, Hajime

AU - Masamune, Atsushi

AU - Unno, Michiaki

N1 - Funding Information: These guidelines were created collaboratively by the Japan Biliary Association, the Research Programs of Intractable Disease for IgG4-related Disease and Intractable Hepato-Biliary Diseases provided by the Ministry of Health, Labor, and Welfare of Japan. This study was supported by a grand-in-aid for the Research Program of Intractable Disease for IgG4-related Disease provided by the Ministry of Health, Labor, and Welfare of Japan. Publisher Copyright: © 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery

PY - 2021/3

Y1 - 2021/3

N2 - Several years have passed since the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then. The Research Committees for IgG4-related Diseases and for Intractable Diseases of the Liver and Biliary Tract, in association with the Ministry of Health, Labor, and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4-SC and have drawn up new clinical diagnostic criteria for IgG4-SC 2020. The diagnosis of IgG4-SC is based on a combination of the following six criteria: (a) narrowing of the intra- or extrahepatic bile duct; (b) thickening of the bile duct wall; (c) serological findings; (d) pathological findings; (e) other organ involvement; and (f) effectiveness of steroid therapy. These new diagnostic criteria for IgG4-SC are useful in practice for general physicians and other non-specialists.

AB - Several years have passed since the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then. The Research Committees for IgG4-related Diseases and for Intractable Diseases of the Liver and Biliary Tract, in association with the Ministry of Health, Labor, and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4-SC and have drawn up new clinical diagnostic criteria for IgG4-SC 2020. The diagnosis of IgG4-SC is based on a combination of the following six criteria: (a) narrowing of the intra- or extrahepatic bile duct; (b) thickening of the bile duct wall; (c) serological findings; (d) pathological findings; (e) other organ involvement; and (f) effectiveness of steroid therapy. These new diagnostic criteria for IgG4-SC are useful in practice for general physicians and other non-specialists.

UR - http://www.scopus.com/inward/record.url?scp=85101826329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101826329&partnerID=8YFLogxK

U2 - 10.1002/jhbp.913

DO - 10.1002/jhbp.913

M3 - Article

C2 - 33586343

AN - SCOPUS:85101826329

SN - 1868-6974

VL - 28

SP - 235

EP - 242

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

IS - 3

ER -

Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this